What Gesund does

Gesund.ai is a Cambridge, Massachusetts-based technology company that operates an AI assurance platform for regulated healthcare AI. The company was founded in 2021 and operates at the intersection of MLOps, regulatory affairs, and clinical evidence generation, serving medical AI developers, bio/medtech firms, and healthcare providers that must demonstrate FDA-grade safety, effectiveness, and equity for their AI-enabled products.

The company's core technology is the Governance, Development, and Assurance Platform (GDAP), a privacy-first MLOps platform supporting the full machine learning lifecycle with federated learning capability. GDAP is delivered through two go-to-market motions: AI CRO, a white-glove managed validation service for pivotal FDA studies (covering study design, data curation, board-certified reader annotation, biostatistics, and regulatory submission support), and AI Factory, a self-serve software platform for in-house AI R&D with flexible on-prem, cloud, and air-gapped deployment. The platform supports multi-modal data (primarily medical imaging — CT, MRI, X-Ray — plus real-world data via PACS integration), ML-native annotation tools, automated bias/fairness analysis, audit trails, version control, drift monitoring, and FDA-ready documentation. A public FDA win includes supporting Prenuvo's Body Composition AI clearance in October 2025, and the company holds ISO 9001:2015, SOC 2 Type II, ISO 27001, and HIPAA certifications.

Gesund.ai monetizes via professional services revenue from the AI CRO managed validation offering and recurring subscription revenue from the AI Factory software platform, both sold through direct enterprise sales with quote-based pricing. The company is privately held and venture-backed by Merck, Northpond Ventures, 500 Global (500 Emerging Europe), Merck Digital Sciences Studio, CancerX Startup Accelerator, Invest 101, ODTÜ TEKNOKENT, and the Turkey Development Fund. Operating geographies span the United States, Europe, Israel, Canada, and the Republic of Korea, and the company is embedded in flagship healthcare-AI governance coalitions including the Coalition for Health AI, NCQA, the American Heart Association, NIST AI RMF alignment, and the White House Health Tech Ecosystem.

Name

Gesund

Legal name

Gesund.ai

Website

https://gesund.ai

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Gesund.ai operates an AI assurance and validation platform (GDAP) that helps medical AI and medtech companies run independent FDA-grade validation studies, supported by a self-serve AI development platform and an ecosystem of clinical and regulatory partners.

Ownership category

akta.pro rank

Product category

Healthcare AI Validation & Governance Software

akta.pro primary industry

Model Governance, Risk & Compliance (GRC) Platforms (HDAAAKAA)

akta.pro secondary industries

Audit, Explainability & Accountability Tooling (traceability, reporting) (HDAAAKAL), Regulatory Readiness & Audit Automation (e.g., EU AI Act, NIST AI RMF, ISO/IEC 42001) (HDAAAMAE), Documentation & Reporting Automation (Model Cards, Datasheets, Impact Assessments) (HDAAAMAJ)

Keywords

• Medical AI validation
• AI assurance platform
• FDA regulatory compliance
• Healthcare AI governance
• Clinical AI MLOps

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. AI CRO Managed Validation Service: White-glove validation service for FDA approval including study design optimization, pivotal studies execution, biostatistical analysis, and ready-to-submit report generation.
2. AI Factory Software Platform: Software platform subscription for in-house AI model development and validation with flexible deployment options (on-prem, cloud, air-gapped).

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Gesund.ai operates a regulatory-grade AI assurance platform (GDAP) that helps healthcare AI companies audit, validate, and monitor medical AI models for FDA regulatory compliance. The company sells two offerings: AI CRO, a white-glove managed validation service for FDA pivotal studies and regulatory submissions, and AI Factory, a self-serve software platform that enables in-house AI model development, annotation, validation, and lifecycle management. Both offerings address the full AI lifecycle from development through FDA approval and post-market monitoring.

Product overview

Gesund.ai is a governance platform for regulated AI, offering two integrated solutions: AI CRO (a managed validation service for white-glove FDA approval support) and AI Factory (a one-stop-shop software platform for in-house AI development). Both solutions are powered by GDAP (Governance Development and Assurance Platform), which provides the regulatory-grade infrastructure including immutable audit trails, human review workflows, version control, and validation pipelines. The platform supports flexible deployment (cloud, on-prem, air-gapped), multi-modal data management (primarily medical imaging with 85% of FDA approvals), and covers the complete AI lifecycle from model development through FDA approval and post-market monitoring. A partner network of readers, hospitals, and data sources complements the technology platform.

Differentiator

Problem solved

Functional benefit

Brands

• GDAP: Governance Development and Assurance Platform - The regulatory-grade platform for AI validation and lifecycle compliance supporting FDA clearance processes.

Products and services

• AI CRO (Validation-as-a-Service) A white-glove managed validation service that runs independent validation studies for medical AI models to facilitate FDA approval. The service spans study design optimization, data curation, expert reader annotation, model prediction generation, biostatistical analysis, comprehensive validation metrics with bias/fairness analysis, and ready-to-submit report generation. Targets medical AI and medtech companies preparing FDA regulatory submissions and pivotal study evidence.
• AI Factory (AI Development Lifecycle Platform) A one-stop-shop software platform that supercharges in-house AI model R&D cycles for bio/pharma and medtech firms. Combines annotation excellence, validation and compliance, data management, and model development/deployment within a no-code platform supporting multi-modal data (CT, MRI, X-Ray, real-world data), Docker/API deployment, AutoML with customizable hyperparameters, and flexible on-prem, cloud, or air-gapped deployment.

Quantifiable outcome

• 4X speed improvement and 2X cost improvement compared to in-house or traditional CRO validation
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability7 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered core, major and flagship.

• Trillium Health PartnerscoreStrategic or Co-development PartnerHealthcare provider partnership for free model validation program. AI Deployment and Evaluation Lab collaborates with Gesund for ethical, transparent validation of health AI models. Provides real-world clinical data for validation.
• NCQAmajorStrategic or Co-development PartnerNational Committee for Quality Assurance partnership. Inaugural participant in AI Governance Working Group establishing standards for AI in healthcare quality measurement.
• American Heart AssociationmajorStrategic or Co-development PartnerCollaboration on healthcare AI standards and guidelines development for cardiovascular AI applications.
• National Institute of Standards and Technology (NIST)majorStrategic or Co-development PartnerCollaboration aligning AI governance framework with NIST AI Risk Management Framework (AI RMF) for standardized risk governance.
• The White HouseflagshipStrategic or Co-development PartnerParticipation in Health Tech Ecosystem launched at the White House, aimed at improving interoperability, patient data mobility, and digital tool availability for Medicare beneficiaries.
• CancerXmajorStrategic or Co-development PartnerPublic-private partnership focused on reducing cancer burden through innovation, collaborating on oncology AI governance standards.
• Digital Medicine Society (DiMe)majorStrategic or Co-development PartnerCollaboration on digital medicine standards and best practices for AI-enabled medical products.
• Coalition for Health AIflagshipStrategic or Co-development PartnerFlagship partnership to advance AI lifecycle assurance for healthcare. Gesund.ai joined forces with coalition to establish standards for independent lifecycle validation.
• Merck AIcoreStrategic or Co-development PartnerMerck's AI division collaboration on healthcare AI development and validation methodologies.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ConcertAI: ConcertAI provides an AI and real-world data platform purpose-built for life sciences and oncology research, including evidence generation and validation workflows. Like Gesund, it serves medical AI developers needing rigorous validation and regulatory-grade evidence, making it the closest direct competitor in healthcare AI assurance.
• Mendel: Mendel offers an AI platform for structuring clinical and biomedical data with explicit focus on transparency, explainability, and audit-ready outputs for regulated healthcare use cases. Comparable to Gesund in addressing AI governance, auditability, and evidence generation needs of healthcare AI developers and providers.
• Arterys (Tempus AI): Arterys built a cloud-native medical imaging AI platform with regulatory-cleared clinical applications, now part of Tempus AI. It is directly comparable to Gesund in addressing FDA-cleared medical imaging AI workflows, and represents a pathway by which an imaging-AI specialist could expand into adjacent validation services.

Emerging players

• Deep 6 AI: Deep 6 AI focuses on AI-driven clinical trial patient matching and real-world data analytics for research operations. It overlaps with Gesund in supporting evidence generation for regulated clinical/AI workflows, though its primary value is patient identification rather than AI model validation.
• ClosedLoop.ai: ClosedLoop.ai is a healthcare-specific AI platform focused on clinical predictive models, with built-in bias detection, explainability, and monitoring tooling for regulated use cases. It is comparable to Gesund's AI Factory in offering MLOps-style tooling for healthcare AI, though it focuses on predictive use cases rather than FDA validation services.

Broad incumbents

• TriNetX: TriNetX operates a global health research network that aggregates real-world clinical data for clinical trial design, feasibility, and post-market surveillance. It is comparable as a platform that supplies the data substrate and analytics layer for evidence generation that companies like Gesund also depend on for AI validation studies.
• Medidata Solutions (Dassault Systèmes): Medidata provides an end-to-end clinical trial technology platform — EDC, RTSM, imaging, and increasingly AI-driven analytics — used by most major life sciences sponsors. As a broad incumbent with established pharma relationships, it is the most likely strategic competitor to bundle AI validation/assurance into its existing clinical trial stack.
• IQVIA: IQVIA is the largest CRO and life sciences services firm, with significant investments in AI for clinical development and real-world evidence. Comparable to Gesund as a competitor for AI-augmented validation and evidence-generation spend, though operating at vastly larger scale across the full drug development lifecycle.
• Tempus Labs: Tempus combines multi-modal data, AI models, and clinical/regulatory infrastructure across oncology and beyond. It overlaps with Gesund in providing AI infrastructure and evidence-generation capabilities for healthcare, but at much broader scope across precision medicine, diagnostics, and biopharma services.
• Verily (Alphabet): Verily is Alphabet's health sciences subsidiary building clinical evidence platforms, real-world data infrastructure, and regulated AI tools for research and care delivery. Comparable to Gesund in tackling healthcare AI governance and evidence generation, but with substantially greater capital, data assets, and Alphabet backing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/gesund-ai
• Xx.com/gesundai

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds5 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gesund